Navigation Links
Pharmaceutical Distributors Continue to Deliver Operational Efficiencies and Value to U.S. Healthcare System Amidst Economic and Regulatory Challenges
Date:11/10/2011

ARLINGTON, Va., Nov. 10, 2011 /PRNewswire-USNewswire/ -- Primary healthcare distributors continue to provide increased value to the healthcare sector while navigating economic, regulatory and business climate challenges in the pharmaceutical industry, according to The Role of Distributors in the U.S. Healthcare Industry released by the Center for Healthcare Supply Chain Research. The Center is the non-profit research foundation of the Healthcare Distribution Management Association (HDMA).  

Building on research studies completed in 2004 and 2007, this industry assessment, conducted by Booz & Company, analyzes the dynamics affecting the healthcare supply chain in the past four years, and provides a qualitative and quantitative assessment of the unique services and value traditional distributors provide to the U.S. healthcare system.

Primary research included interviews conducted by the Booz & Company team with executives from across the healthcare supply chain — generic and branded manufacturers; regional and national distributors; as well as providers and industry experts — on a wide variety of issues, as well as information from Center and third-party data sources. Secondary research comprised analyst reports, IMS Health information, HDMA Factbook data, news articles and other industry studies.      

"Since it was first published in 2004, The Role of Distributors in the U.S. Healthcare Industry has served as a window into the evolution of the healthcare distribution industry," said Karen J. Ribler, Executive Vice President and COO, the Center for Healthcare Supply Chain Research. "It not only demonstrates the vital role distributors play, but answers the question of how pharmaceuticals flow through the industry, highlights fundamental changes that have occurred in the past four years and underscores long-term implications for distributors."  

According to the study, t
'/>"/>

SOURCE Center for Healthcare Supply Chain Research
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 1, 2014 In the latest call for ... dysfunction, more than 60 doctors and leading medical experts ... questioning the Food and Drug Administration,s (FDA) decision to ... of male sexual dysfunction compared with ZERO for women,s ... act for women by approving the first-ever drug to ...
(Date:8/1/2014)... 2014 In the latest call for gender ... more than 60 doctors and leading medical experts from ... the Food and Drug Administration,s (FDA) decision to approve ... male sexual dysfunction compared with ZERO for women,s most ... for women by approving the first-ever drug to treat ...
(Date:8/1/2014)... Aspire Technology Partners (Aspire) announced today that it ... This designation recognizes Aspire for delivering outstanding customer service to ... . "Achieving exceptional results for our customers is ... President and CEO of Aspire. "We are pleased Cisco has ... award and are proud to be part of the Cisco ...
Breaking Medicine Technology:60+ Healthcare Professionals Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Healthcare Professionals Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 360+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 260+ Doctors and Leading Medical Experts Sign an Open Letter Urging the FDA to Approve First-Ever Drug to Treat Women's Most Common Form of Sexual Dysfunction, notes Even the Score 3Aspire Technology Partners Recognized By Cisco For Excellence In Customer Satisfaction 2
... May 3, 2012 /PRNewswire-Asia/ -- Johnson & ... has acquired Guangzhou Bioseal Biotechnology Co., Ltd. ... in the design, development and commercialization of ... bleeding during surgery. The acquisition was completed ...
... Cochlear Americas , the world,s leading implantable hearing ... smartphone support application for Nucleus® Cochlear Implant recipients. ... App as part of Cochlear,s mobile support initiative, ... and wherever they need it. (Photo: ...
Cached Medicine Technology:Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd. 2Cochlear™ Americas Adds the Nucleus® Support App to its Mobile Service Offerings 2
(Date:8/1/2014)... Medicine in St. Louis helps explain why brain tumors ... harmful than similar tumors in females. For example, glioblastomas, ... as often in males, who suffer greater cognitive impairments ... The researchers found that retinoblastoma protein (RB), a protein ... in male brain cells than in female brain cells. ...
(Date:8/1/2014)... News) -- The U.S. Food and Drug Administration announced ... to help fight type 2 diabetes. Jardiance ... treatment regimens to control blood sugar levels in the ... the Office of Drug Evaluation II in the FDA,s ... agency statement. The FDA also recommended that Jardiance ...
(Date:8/1/2014)... August 01, 2014 The evolving ... independent community pharmacies. At ThoughtSpot 2014, AmerisourceBergen and ... with practices and resources to enhance patient care ... focused on critical issues to give independent pharmacists ... grow. , ThoughtSpot show attendance experienced a ...
(Date:8/1/2014)... Texas (PRWEB) August 01, 2014 ... health coverage and healthcare reforms are boosting healthcare ... of medicines through discounts and increasing generic consumption ... at approximately 76.7 million in 2013, having grown ... 1.4%, from 2008. The implementation of the Health ...
(Date:8/1/2014)... News) -- Patients with the progressive, deadly respiratory ailment ... new weapon to battle the disease, the U.S. Food ... approved a new treatment, an inhaled spray called Striverdi ... Americans. COPD, which is often linked to smoking, involves ... Patients with COPD may experience a number ...
Breaking Medicine News(10 mins):Health News:Study reveals one reason brain tumors are more common in men 2Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 3Health News:ThoughtSpot 2014 Inspires as General Session Concludes 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 5Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:FDA Approves New Treatment for People With COPD 2
... industrial chemicals in the environment can damage the developing ... deficit disorder (ADHD), and mental retardation. Still, there has ... that can cause injury to the developing brains of ... in the print issue of The Lancet researchers from ...
... 47-year-old woman who lost her hands in a chemical explosion some ... This is the first of its kind done in Spain, and ... the Pedro Cavadas Foundation performed this ten- hour operation. ... and may be released from hospital next week and should get ...
... US HIV/AIDS healthcare provider will soon be reaching out ... Assam to provide treatment and support//. ,The US-based ... counselling and testing centres in Assam's main city of ... city of Silchar. ,India's National AIDS ...
... with yet another significant product from soybean. A study ... made from soy has amazing restorative powers. ... Jefferson Medical College found that giving doses of a ... animals’ ability to move and walk. ,Over ...
... the senior citizens have become sensitive to health issues, and ... under control. ,Study author, Bernard M.Y. Cheung, said,"It ... We have tried to see if the explanation lies in ... increase in these, so probably all of these contribute in ...
... now be made more easily available to critically ill patients. ... that will enable patients// who are extremely ill to try ... options. ,The FDA has announced that they will ... to be made available to needy individuals .They will also ...
Cached Medicine News:Health News:Industrial Chemicals Are Impairing the Brain Development of Children Worldwide 2Health News:Industrial Chemicals Are Impairing the Brain Development of Children Worldwide 3Health News:Industrial Chemicals Are Impairing the Brain Development of Children Worldwide 4Health News:US NGO to Counsel HIV/AIDS Patients in Assam 2Health News:Soy’s Restorative Powers Confirme 2
The Hilan pneumatic high speed drill system consists of a pneumatic motor and drill with various cutting attachments....
The XK-95 High Speed Drill System sets new technological and performance standards for surgical drill systems....
Circular Spine Retractor System for microsurgical interventions in the lumbar and cervical spine region. The system has been approved in over 120 cases....
... The Ruggles Retractor System, a ... and the versatility of two systems ... hands from the surgical site during ... accurate retractor insertion. The retractor body ...
Medicine Products: